<?xml version="1.0" encoding="UTF-8"?>
<ref id="B364-viruses-12-00110">
 <label>364.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mercorelli</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Luganini</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Nannetti</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Tabarrini</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Palu</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Gribaudo</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Loregian</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>drug repurposing approach identifies inhibitors of the prototypic viral transcription factor IE2 that block human cytomegalovirus replication</article-title>
  <source>Cell Chem. Biol.</source>
  <year>2016</year>
  <volume>23</volume>
  <fpage>340</fpage>
  <lpage>351</lpage>
  <pub-id pub-id-type="doi">10.1016/j.chembiol.2015.12.012</pub-id>
  <pub-id pub-id-type="pmid">26877023</pub-id>
 </element-citation>
</ref>
